文献速递衰弱、肌少症与跌倒老年慢病共病管理

住院老年COVID-19患者衰弱与死亡率:回顾性观察研究

Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study.
PubMed 文献 · J Am Med Dir Assoc · 2020-06-09

6周内18例死亡,死亡率与年龄、CFS评分、基线LDH、淋巴细胞计数及RT-PCR Ct值相关;多变量分析中CFS、LDH和RT-PCR Ct值独立关联死亡,而年龄不独立关联。结论提示即使高龄和重度衰弱患者,在资源充足时仍可能从住院获益。

要点

  • 6周内18例死亡,死亡率与CFS评分、LDH、淋巴细胞计数及RT-PCR Ct值相关。
  • 多变量分析中CFS、LDH和RT-PCR Ct值独立关联死亡,年龄不独立关联。
  • 年龄和衰弱预测生存的特异性均差,联合年龄、CFS、LDH和病毒载量的模型可显著预测生存。

核心结论

  • 尽管高龄和重度衰弱患者预后更差,但在资源充足时仍可能从COVID-19住院治疗中获益。

主要发现

  • 参与者中女性48例(59%),中位年龄85岁(范围65-97岁),中位CFS评分7分(范围2-9分),42例(52%)为长期护理机构居住者。
  • 6周内18例患者死亡。
  • 死亡率与年龄(Spearman r=0.241,P=.03)、CFS评分(r=0.282,P=.011)、基线LDH(r=0.301,P=.009)、淋巴细胞计数(r=-0.262,P=.02)及RT-PCR Ct值(r=-0.285,P=.015)显著但弱相关。
  • 死亡率与长期护理机构居住、痴呆、谵妄或多重用药无关。
  • 多变量logistic回归分析中,CFS、LDH和RT-PCR Ct值(而非年龄)仍独立关联死亡率。

临床怎么用

  • 对住院老年COVID-19患者应评估衰弱(CFS),并结合LDH、淋巴细胞计数和RT-PCR Ct值综合判断死亡风险。
  • 不应仅因高龄或重度衰弱而放弃住院治疗,在资源充足时这类患者仍可能从住院中获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the association between frailty and short-term mortality in older adults hospitalized for coronavirus disease 2019 (COVID-19). DESIGN: Retrospective single-center observational study. SETTING AND PARTICIPANTS: Eighty-one patients with COVID-19 confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR), at the Geriatrics department of a general hospital in Belgium. MEASUREMENTS: Frailty was graded according to the Rockwood Clinical Frailty Scale (CFS). Demographic, biochemical, and radiologic variables, comorbidities, symptoms, and treatment were extracted from electronic medical records. RESULTS: Participants (N = 48 women, 59%) had a median age of 85 years (range 65-97 years) and a median CFS score of 7 (range 2-9); 42 (52%) were long-term care residents. Within 6 weeks, 18 patients died. Mortality was significantly but weakly associated with age (Spearman r = 0.241, P = .03) and CFS score (r = 0.282, P = .011), baseline lactate dehydrogenase (LDH; r = 0.301, P = .009), lymphocyte count (r = -0.262, P = .02), and RT-PCR cycle threshold (Ct, r = -0.285, P = .015). Mortality was not associated with long-term care residence, dementia, delirium, or polypharmacy. In multivariable logistic regression analyses, CFS, LDH, and RT-PCR Ct (but not age) remained independently associated with mortality. Both age and frailty had poor specificity to predict survival. A multivariable model combining age, CFS, LDH, and viral load significantly predicted survival. CONCLUSIONS AND IMPLICATIONS: Although their prognosis is worse, even the oldest and most severely frail patients may benefit from hospitalization for COVID-19, if sufficient resources are available.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. De Smet R, Mellaerts B, Vandewinckele H, et al. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. J Am Med Dir Assoc. 2020. PMID: 32674821. doi:10.1016/j.jamda.2020.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。